
FROM INNOVATION TO IMPACT
The Office of Technology Licensing & Commercialization works to ensure that great ideas find their way out of the lab and into the hands of the people who need them. It plays a critical role in developing and protecting the intellectual property of Georgia State faculty, staff and students. The office makes these discoveries available to business, industry and trade partners, driving economic growth and providing an opportunity for the public to benefit from researchers’ breakthroughs.
165 Total active technologies based on Georgia State research
14 Startups led by Georgia State University faculty
205 Patents issued to Georgia State University researchers
Information for Researchers
Our office provides the resources and expertise to guide your innovation into the marketplace.
Information for Industry
We partner with entrepreneurs, business leaders and investors to facilitate the commercialization of our scientists’ discoveries.
Research Commercialization News

The drug targets a cell surface receptor that is expressed on cancer-associated fibroblasts, cells that generate collagen and other fibrous molecules and can be mobilized into service by a tumor.

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.

Faculty have received $3 million to further develop a tool that will allow researchers to participate in brain imaging analysis without sharing protected patient data.
Contact Us
Cliff Michaels, Ph.D.
Director, Office of Technology Licensing and Commercialization
Office: 58 Edgewood Avenue, Room 344
Phone: (404) 413-6687
Email: cmichaels@gsu.edu
Cheryl Costen Hibbler
Senior Administrative Specialist Admin,
Office of Technology Licensing and Commercialization
Office: 58 Edgewood Avenue, Room 372
Phone: (404) 413-3558
Email: chibbler@gsu.edu